Urinary Tract Infection
📧 Sign up to get email alerts when something new happens for Urinary Tract Infection.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2021-06-25FDA Approved: NITROFURANTOIN — Original Application (Alembic Pharmaceuticals Limited)
FDA approves Alembic Pharmaceuticals Limited's original application for nitrofurantoin, a generic antibiotic for urinary tract infections.
-
CLINICAL_TRIALS trial_result · 2021-02-18Clinical Trial Update: Evaluation of the Efficacy and Safety of MV140 [Phase 3]
Phase 3 clinical trial evaluating efficacy and safety of MV140 for bacterial urinary tract infections has completed.
-
FDA approval · 2021-01-21FDA Approved: NITROFURANTOIN MONOHYDRATE/ MACROCRYSTALLINE — Supplemental Application (Alvogen Inc.)
The FDA approved a supplemental application for nitrofurantoin monohydrate/macrocrystalline (Alvogen). This action confirms regulatory autho…
-
FDA approval · 2021-01-21FDA Approved: NITROFURANTOIN MACROCRYSTALS — Supplemental Application (Alvogen Inc.)
The FDA approved a supplemental application for Nitrofurantoin Macrocrystals from Alvogen, approving the new formulation and related labelin…
-
CLINICAL_TRIALS trial_result · 2021-01-14Clinical Trial Update: Antibiotic Bladder Instillations vs. Oral Suppression for the Treatment of Recurrent Urinary Tract Infections [Phase 4]
Phase 4 clinical trial update comparing antibiotic bladder instillations to oral suppression for recurrent urinary tract infections.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2020-12-23FDA Approved: NITROFURANTOIN — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for nitrofurantoin filed by Rising Pharma Holdings, Inc., reflecting a change to the drug's labe…
-
CLINICAL_TRIALS trial_result · 2020-12-19Clinical Trial Update: Safety and Efficacy Study of Oral Fosfomycin Versus Oral Levofloxacin to Treat Complicated Urinary Syndromes (FOCUS) [Phase 4]
Phase 4 trial comparing oral fosfomycin to oral levofloxacin for complicated urinary syndromes has been terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2020-12-14Clinical Trial Update: Oral vs Initial Intravenous Antibiotic Treatment of Urinary Tract Infections in Children: a RCT [Phase 3]
A Phase 3 randomized trial comparing oral versus initial intravenous antibiotic treatment for urinary tract infections in children has been …
-
FDA approval · 2020-11-27FDA Approved: METHENAMINE HIPPURATE — Original Application (Ingenus Pharmaceuticals, LLC)
FDA approved the original application for methenamine hippurate, a generic product from Ingenus Pharmaceuticals, LLC. It is indicated for th…
-
CLINICAL_TRIALS trial_result · 2020-10-28Clinical Trial Update: Seven vs. 14 Days Treatment for Male Urinary Tract Infection [NA]
Clinical trial comparing seven versus fourteen days of treatment for male urinary tract infection has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-09-21Clinical Trial Update: Vaginal Estrogen for the Prevention of Recurrent Urinary Tract Infection in Postmenopausal Women [Phase 4]
Phase 4 trial update on vaginal estrogen for preventing recurrent urinary tract infections in postmenopausal women has completed with result…
-
FDA approval · 2020-07-28FDA Approved: BACTRIM — Supplemental Application (Sun Pharmaceutical Industries, Inc)
FDA approved a supplemental application for BACTRIM (sulfamethoxazole and trimethoprim) filed by Sun Pharmaceutical Industries, Inc. to upda…
-
CLINICAL_TRIALS trial_result · 2020-07-13Clinical Trial Update: The SCOUT Study: "Short Course Therapy for Urinary Tract Infections in Children" [Phase 2]
Phase 2 clinical trial completed evaluating short-course therapy for urinary tract infections in children; results posted in 2020.
-
FDA approval · 2020-04-22FDA Approved: LEVOFLOXACIN — Original Application (Gland Pharma Limited)
FDA approved an original application for levofloxacin from Gland Pharma Limited, authorizing a generic version of the antibiotic.
-
CLINICAL_TRIALS trial_result · 2020-04-22Clinical Trial Update: Treating Pyelonephritis an Urosepsis With Pivmecillinam [Phase 4]
Phase 4 trial update evaluating pivmecillinam for pyelonephritis and urinary tract infections has completed.
-
CLINICAL_TRIALS trial_result · 2020-03-18Clinical Trial Update: High Strength Cranberry Supplementation for Prevention of Recurrent Urinary Tract Infection [Phase 2]
Phase 2 trial investigating high-strength cranberry supplementation for prevention of recurrent urinary tract infection has completed.
-
CLINICAL_TRIALS trial_result · 2020-03-18Clinical Trial Update: Preventing UTIs in Chronic Neurogenic Bladder Dysfunction (Mix Methods) [Phase 2]
Phase 2 clinical trial update on preventing urinary tract infections in individuals with chronic neurogenic bladder dysfunction; study compl…
-
CLINICAL_TRIALS trial_result · 2020-02-27Clinical Trial Update: Restricted Reporting for Positive Urine Cultures [NA]
A completed clinical trial update regarding restricted reporting for positive urine cultures for conditions related to bacteriuria and urina…
-
CLINICAL_TRIALS trial_result · 2020-02-18Clinical Trial Update: Reducing Urinary Tract Infection Rates Using a Controlled Aseptic Protocol for Catheter Insertion [Phase 2]
Phase 2 trial evaluating a controlled aseptic protocol for catheter insertion to reduce urinary tract infections; study completed with resul…
-
CLINICAL_TRIALS trial_result · 2020-02-17Clinical Trial Update: TRA for Preventing Symptomatic Urinary Tract Infection Among High-risk Elderly Residing in Nursing Homes [Phase 2]
Phase 2 trial update evaluating a treatment to prevent symptomatic urinary tract infections in high-risk elderly residents of nursing homes …
-
FDA approval · 2020-01-27FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for Amoxicillin and clavulanate potassium by Sandoz Inc.
-
CLINICAL_TRIALS trial_result · 2020-01-07Clinical Trial Update: Pharmacokinetic Study of Oral Gepotidacin (GSK2140944) in Subjects With Uncomplicated Urinary Tract Infection (Acute Cystitis) [Phase 2]
Phase 2 pharmacokinetic study of oral gepotidacin in uncomplicated urinary tract infection (acute cystitis) completed; results posted.
-
CLINICAL_TRIALS trial_result · 2019-12-12Clinical Trial Update: A Study of Efficacy and Safety of Intravenous Cefiderocol (S-649266) Versus Imipenem/Cilastatin in Complicated Urinary Tract Infections [Phase 2]
Phase 2 trial comparing intravenous cefiderocol to imipenem/cilastatin for complicated urinary tract infections has completed with results p…
-
CLINICAL_TRIALS trial_result · 2019-11-27Clinical Trial Update: Reducing Antibiotic Use for Uncomplicated Urinary Tract Infection in General Practice by Treatment With Uva Ursi (UU)- a Comparative Effectiveness Trial [Phase 4]
A Phase 4 comparative effectiveness trial evaluated reducing antibiotic use for uncomplicated urinary tract infections in general practice u…
-
CLINICAL_TRIALS trial_result · 2019-10-14Clinical Trial Update: Effects of Antibiotic Prophylaxis on Recurrent UTI in Children [Phase 4]
Phase 4 clinical trial evaluating how antibiotic prophylaxis affects recurrence of urinary tract infections in children; study completed wit…